Unknown

Dataset Information

0

Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.


ABSTRACT: We previously reported that malignant melanomas express high levels of the mRNA binding protein coding region determinant binding protein (CRD-BP). This molecule is important for the activation of anti-apoptotic pathways, a mechanism often linked to insensitivity to therapeutics. However, it is not known whether CRD-BP plays a role in the resistance of melanomas to anti-cancer treatment. Here we demonstrate that knockdown of CRD-BP with a specific sh-RNA enhances the effect of dacarbazine, temozolomide, vinblastine, and etoposide on both primary and metastatic melanoma cell lines. CRD-BP down-regulation contributes to cell sensitization by increasing apoptosis and diminishing melanoma cell growth in response to chemotherapeutic agents. Furthermore, inhibition of CRD-BP decreases microphthalmia-associated transcription factor (MITF) expression and reintroduction of MITF partially compensates for the absence of CRD-BP. These findings suggest that high expression of CRD-BP in melanoma cells confers resistance to chemotherapy and that these CRD-BP responses are mediated, at least in part, by MITF.

SUBMITTER: Craig EA 

PROVIDER: S-EPMC3242936 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.

Craig Evisabel A EA   Spiegelman Vladimir S VS  

Pigment cell & melanoma research 20111028 1


We previously reported that malignant melanomas express high levels of the mRNA binding protein coding region determinant binding protein (CRD-BP). This molecule is important for the activation of anti-apoptotic pathways, a mechanism often linked to insensitivity to therapeutics. However, it is not known whether CRD-BP plays a role in the resistance of melanomas to anti-cancer treatment. Here we demonstrate that knockdown of CRD-BP with a specific sh-RNA enhances the effect of dacarbazine, temoz  ...[more]

Similar Datasets

| S-EPMC8008117 | biostudies-literature
| S-EPMC5300761 | biostudies-literature
| S-EPMC6534361 | biostudies-literature
| S-EPMC3638355 | biostudies-literature
| S-EPMC3835084 | biostudies-literature
| S-EPMC2898355 | biostudies-literature
| S-EPMC147974 | biostudies-other
| S-EPMC4281741 | biostudies-literature
| S-EPMC3362893 | biostudies-other
| S-EPMC4505587 | biostudies-literature